Immucor’s Q1 Profit Jumps 7% on Higher Sales (BLUD)
October 2nd, 2009

Blood transfusion products maker Immucor, Inc. (BLUD) said Thursday that its first quarter profit rose 7% from last year, helped by higher sales across its product lines.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!



Stock Screener
RSS
Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the